Marcie Riches
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation 22
- Acute Myeloid Leukemia Research 6
- Infectious Diseases top 10%
-
- CAR-T cell therapy research 6
- Neutropenia and Cancer Infections 6
-
- Immune Cell Function and Interaction 5
-
- Acute Lymphoblastic Leukemia research 8
- Palliative Care and End-of-Life Issues 6
-
- Cytomegalovirus and herpesvirus research 5
- Co-authors
- Bronwen E. ShawRoy F. ChemalyMiguel‐Angel PeralesChristopher E. DandoyLohith GowdaNeel S. BhattJenni BloomquistJordan Gauthier
- Journals
- Journal of Clinical Oncology (2 papers)Blood (6 papers)British Journal of Haematology (1 paper)
- Partner nations
- United StatesSpainCanada
In The Last Decade
Marcie Riches
40 papers receiving 551 citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Hematology 263
- Infectious Diseases 211
- Oncology 209
- Immunology 118
- Transplantation 12
Countries citing papers authored by Marcie Riches
This map shows the geographic impact of Marcie Riches's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcie Riches with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcie Riches more than expected).
Fields of papers citing papers by Marcie Riches
This network shows the impact of papers produced by Marcie Riches. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcie Riches. The network helps show where Marcie Riches may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marcie Riches, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 6 | |
| 6 | 2021 | 3 | |
| 7 | 2021 | 1 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 17 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 6 | |
| 13 | 2020 | 7 | |
| 14 | 2018 | 8 | |
| 15 | 2017 | 0 | |
| 16 | 2016 | 8 | |
| 17 | 2016 | 37 | |
| 18 | 2015 | 6 | |
| 19 | 2015 | 24 | |
| 20 | 2015 | 15 |
About Marcie Riches
Marcie Riches is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health, having authored 43 papers that have together received 555 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (22 papers), Acute Lymphoblastic Leukemia research (8 papers), Acute Myeloid Leukemia Research (6 papers), CAR-T cell therapy research (6 papers), Neutropenia and Cancer Infections (6 papers), Palliative Care and End-of-Life Issues (6 papers), Immune Cell Function and Interaction (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). The work is most often cited by research in Hematology (263 citations), Infectious Diseases (211 citations) and Oncology (209 citations). Marcie Riches has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Bronwen E. Shaw, Roy F. Chemaly, Miguel‐Angel Perales, Christopher E. Dandoy, Lohith Gowda, Neel S. Bhatt, Jenni Bloomquist, Jordan Gauthier, Andrew St. Martin and Amer M. Zeidan. Their work appears in journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.